Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

BACKGROUND: Bronchodilator medications are central to the symptomatic management of chronic obstructive pulmonary disease (COPD). Metered-dose inhalers (MDIs) are the most commonly used devices to deliver treatment to patients with COPD and asthma, comprising approximately 70% of bronchodilator pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Rennard, Stephen, Fogarty, Charles, Reisner, Colin, Fernandez, Carlos, Fischer, Tracy, Golden, Michael, Rose, Earl St, Darken, Patrick, Tardie, Gregory, Orevillo, Chadwick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124171/
https://www.ncbi.nlm.nih.gov/pubmed/25027304
http://dx.doi.org/10.1186/1471-2466-14-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124171/
https://www.ncbi.nlm.nih.gov/pubmed/25027304
http://dx.doi.org/10.1186/1471-2466-14-118

Ejemplares similares